“…Rce1p is reportedly insensitive to many broadspectrum inhibitors, such as EDTA, EGTA, antipain, chymostatin, pepstatin A, leupeptin, E64, and is partially sensitive to MMTS. It should be noted that the sensitivity of Rce1p to the serine protease inhibitors PMSF and DFP and the alkylating agent NEM has been inconsistently reported [24,27,30,31]. The second class of Rce1p inhibitors is represented by substrates with non-cleavable peptide bonds, isoprenoid-like compounds, and bisubstrate analogues (i.e., compounds containing both a farnesylmimetic and peptidomimetic).…”